The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Fluorescein Sodium and Benoxinate Hydrochloride
Fluorescein Sodium and Benoxinate Hydrochloride · FLUORESCEIN SODIUM 2.6 mg/mL; BENOXINATE HYDROCHLORIDE 4.4 mg/mL · Solution/ Drops · Ophthalmic · Bausch & Lomb Incorporated
NDC 24208-0734-05 · 1 BOTTLE, GLASS in 1 CARTON / 5 mL in 1 BOTTLE, GLASS · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA211039
- TE code
- —
- Approval date
- Mar 9, 2020
- Patents / exclusivity
- 3 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 10842872 | Nov 15, 2037 |
| patent | 10632197 | Nov 15, 2037 |
| patent | 10293047 | Nov 15, 2037 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fluorescein Sodium and Benoxinate Hydrochloride (Solution/ Drops)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | FLUORESCEIN SODIUM 2.6 mg/mL; BENOXINATE HYDROCHLORIDE 4.4 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Bausch & Lomb Incorporated | FLUORESCEIN SODIUM 2.6 mg/mL; BENOXINATE HYDROCHLORIDE 4.4 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Bausch & Lomb Americas Inc. | FLUORESCEIN SODIUM 4.4 mg/mL; BENOXINATE HYDROCHLORIDE 2.6 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Bausch & Lomb Incorporated | FLUORESCEIN SODIUM 4.4 mg/mL; BENOXINATE HYDROCHLORIDE 2.6 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Bausch & Lomb Americas Inc. | BENOXINATE HYDROCHLORIDE 4.4 mg/mL; FLUORESCEIN SODIUM 2.6 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
| Bausch & Lomb Incorporated | BENOXINATE HYDROCHLORIDE 4.4 mg/mL; FLUORESCEIN SODIUM 2.6 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fluorescein Sodium and Benoxinate Hydrochloride — NDC 24208-0734-05," retrieved September 3, 2026, https://drugdashboards.com/drug/24208073405.
Free to cite with attribution — see how the data is put together.